Official EU label nameGlossary entry 22565
POTASSIUM BROMATE
This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.
Global evidence snapshot
The resolved identity has matching regulatory evidence in 10 of 13 indexed market datasets: 9 country records and 1 EU Annex records. Every result and evidence gap is listed below.
Markets checked
13
Markets with evidence
10
Evidence gaps
3
Resolved identifiers
3
Resolved substance identity
CAS:7758-01-27789-38-0
EC:231-829-8
Ingredient index records:
7 matched or reported names
POTASSIUM BROMATEPotassium bromateBromates溴酸钾 — Potassium bromate （CAS No. 7758-01-2）포타슘브로메이트Bromato de potássio, exceto em produtos para ondular cabelos, na concentração máxima de 10 %Potassium bromate (CAS No. 7758-01-2)
Regulatory evidence in all 13 markets
Open each matched record for its scope, concentration, conditions, warnings and official source version.
Swipe or scroll horizontally to see dataset coverage and next actions.
| Market | Result | Records | Dataset | Meaning / next action |
|---|---|---|---|---|
| European Union EU | Prohibited | 1Open record 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | Review every linked record and exact conditions. |
| Great Britain GB | Prohibited | 1Open record 1 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | Review every linked record and exact conditions. |
| Canada CA | Prohibited | 1Open record 1 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | Review every linked record and exact conditions. |
| New Zealand NZ | Prohibited | 1Open record 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | Review every linked record and exact conditions. |
| ASEAN ASEAN | Prohibited | 1Open record 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Review every linked record and exact conditions. |
| China CN | Prohibited | 1Open record 1 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | Review every linked record and exact conditions. |
| Japan JP | No local match | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Prohibited | 1Open record 1 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Review every linked record and exact conditions. |
| United States US | No local match | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | No local match | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | Prohibited | 1Open record 1 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | Review every linked record and exact conditions. |
| India IN | Prohibited | 1Open record 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | Review every linked record and exact conditions. |
| Saudi Arabia SA | Prohibited | 1Open record 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | Review every linked record and exact conditions. |
No market rows match this filter.
Matching market records and conditions
Great Britain
GB retained Regulation 1223/2009 schedules, effective 15 August 2026Canada
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026China
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025South Korea
MFDS Notice 2026-19, effective 18 March 2026Brazil
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026Exact Annex II–VI evidence
Annex IIentry 461
Open full regulatory recordPotassium bromate
Chemical identity and properties
CAS 7758-01-2PubChem CID 23673461
Potassium Bromate
Potassium bromate is a bromate salt and a potassium salt. It has a role as a flour treatment agent. — ChEBI
- IUPAC name
- potassium bromate
- Molecular formula
- BrKO3
- Molecular weight
- 167.00 g/mol
- Exact mass
- 165.86679 Da
- Topological polar surface area
- 57.2 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 3
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
Bromic acid, potassium saltpotassium trioxobromate04MB35W6ZACHEBI:38211NSC-215200E924RefChem:175433231-829-8
16 more reported names
potassium;bromateBromate, potassiumBrKO3Potassium bromate(DOT)KaliumbromatCCRIS 529EEC No. E924HSDB 1253EINECS 231-829-8UN1484NSC 215200potassium bromate-bromide0.033M Potassium bromateUNII-04MB35W6ZAPotassium bromate ACS reagentpotassium trioxidobromate(1-)
External database identifiers
- ChEBI:CHEBI:38211
- ChEMBL:CHEMBL2311074
- EPA DTXSID:DTXSID6020195
- PubMed:40682247
- PubMed:38301995
- PubMed:37865952
- PubMed:36284482
- PubMed:34196753
- PubMed:33219891
- PubMed:30559759
- PubMed:30008028
- PubMed:28321044
- PubMed:27082013
- PubMed:27074584
- PubMed:26296324
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 7789-38-0PubChem CID 23668195
Sodium Bromate
Sodium bromate is an inorganic sodium salt having bromate as the counterion. It has a role as a nephrotoxic agent and an oxidising agent. It is a bromate salt and an inorganic sodium salt. — ChEBI
- IUPAC name
- sodium bromate
- Molecular formula
- BrNaO3
- Molecular weight
- 150.89 g/mol
- Exact mass
- 149.89285 Da
- Topological polar surface area
- 57.2 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 3
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
Bromic acid, sodium saltDyetoneBromate de sodiumNeutralizer K-126Neutralizer K-140Neutralizer K-938Sodium bromate(DOT)Sodium bromate (NaBrO3)
16 more reported names
U54JK6453ONaBrO3CHEBI:75229NSC-77383RefChem:887354232-160-4sodium;bromateBromate de sodium [French]HSDB 2185EINECS 232-160-4NSC 77383UN1494UNII-U54JK6453OCCRIS 9265EC 232-160-4Bromic acid, sodium salt (1:1)
External database identifiers
- ChEBI:CHEBI:75229
- ChEMBL:CHEMBL1348453
- EPA DTXSID:DTXSID9023837
- PubMed:29594315
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Additional authoritative substance research
Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight
Take this record further
Official source and scope
Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.
Open official Decision